Endurant Capital Management LP
Regulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
Portfolio style
Measured from the filed 13F common-share book for Dec 31, 2023, never from the firm's own description.
Closest benchmark: the Russell 1000 as of 2023-12-31, active share 97.8%; sector active share 77.3% against the combined 13F book's sector weights.
Over time 16 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
24 tracked positions · as of Dec 31, 2023 · Δ vs Sep 30, 2023Portfolio Trend
Sector Breakdown
As of Dec 31, 2023| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 88.9% | $14,709,980 |
| Unclassified | 9.4% | $1,547,722 |
| Real Estate | 1.7% | $285,642 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedTrimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| AVTR | Avantor, Inc. | −202,279 | 24,598 | $561,572 | |
| SBRA | Sabra Health Care REIT, Inc. | −183,775 | 20,017 | $285,642 | |
| BMRN | Biomarin Pharmaceutical Inc | −174,918 | 4,650 | $448,353 | |
| KIDS | Orthopediatrics Corp | −56,936 | 13,428 | $436,544 | |
| QDEL | QuidelOrtho Corp | −21,600 | 5,147 | $379,333 | |
| THC | Tenet Healthcare Corp | −19,848 | 7,303 | $551,887 | |
| ZBH | Zimmer Biomet Holdings, Inc. | −11,833 | 5,646 | $687,118 | |
| ELV | Elevance Health, Inc. | −10,874 | 2,627 | $1,238,788 | |
| COR | Cencora, Inc. | −10,616 | 990 | $203,326 | |
| COO | Cooper Companies, Inc. | −10,545 | 988 | $373,898 | |
| TMO | Thermo Fisher Scientific Inc. | −10,055 | 3,794 | $2,013,817 | |
| BSX | Boston Scientific Corp | −8,785 | 39,108 | $2,260,833 | |
| — | −6,119 | 11,631 | $831,035 | ||
| HUM | Humana Inc | −6,115 | 469 | $214,712 | |
| PODD | Insulet Corp | −4,972 | 3,906 | $847,523 | |
| CI | Cigna Group | −4,699 | 1,384 | $414,438 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| — | 24,871 | $1,547,722 | ||
| ICLR | Icon PLC | 3,659 | $1,035,753 | |
| EHC | Encompass Health Corp | 12,870 | $858,686 | |
| PFE | Pfizer Inc | 15,790 | $454,594 | |
| A | Agilent Technologies, Inc. | 1,900 | $264,157 | |
| FTRE | Fortrea Holdings Inc. | 6,988 | $243,881 | |
| QGEN | Qiagen N.V. | 5,219 | $233,912 | |
| ACRS | Aclaris Therapeutics, Inc. | 148,400 | $155,820 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| BRKR | Bruker Corp | 111,276 | $6,932,494 | |
| MRK | Merck & Co., Inc. | 44,384 | $4,569,332 | |
| ARGX | Argenx SE | 9,108 | $4,477,766 | |
| CNMD | CONMED Corp | 41,984 | $4,234,086 | |
| TXG | 10x Genomics, Inc. | 71,044 | $2,930,565 | |
| OHI | Omega Healthcare Investors Inc | 80,070 | $2,655,121 | |
| SYK | Stryker Corp | 7,547 | $2,062,368 | |
| INSM | INSMED Inc | 79,471 | $2,006,642 | |
| DXCM | Dexcom Inc | 20,694 | $1,930,750 | |
| ABT | Abbott Laboratories | 18,040 | $1,747,174 | |
| — | 82,153 | $1,268,442 | ||
| OCUL | Ocular Therapeutix, Inc | 353,707 | $1,110,639 | |
| AZTA | Azenta, Inc. | 19,422 | $974,790 | |
| TARS | Tarsus Pharmaceuticals, Inc. | 47,649 | $846,722 | |
| AHCO | AdaptHealth Corp. | 89,937 | $818,426 | |
| AXSM | Axsome Therapeutics, Inc. | 11,254 | $786,542 | |
| IQV | Iqvia Holdings Inc. | 3,946 | $776,375 | |
| OLMA | Olema Pharmaceuticals, Inc. | 58,573 | $723,376 | |
| — | 18,458 | $641,046 | ||
| — | 14,158 | $507,989 | ||
| GDRX | GoodRx Holdings, Inc. | 87,290 | $491,442 | |
| RNAC | Cartesian Therapeutics, Inc. | 453,314 | $480,512 | |
| TLT | iShares 20+ Year Treasury Bond ETF | 3,400 | $301,546 | |
| NVST | Envista Holdings Corp | 10,787 | $300,741 | |
| ADAPY | Adaptimmune Therapeutics PLC | 311,944 | $243,316 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| BSX |
Boston Scientific Corp
Healthcare
|
Reduced | 39,108 | $2,260,833 | 13.67% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Reduced | 3,794 | $2,013,817 | 12.17% | |
|
|
NEW | 24,871 | $1,547,722 | 9.36% | ||
| ELV |
Elevance Health, Inc.
Healthcare
|
Reduced | 2,627 | $1,238,788 | 7.49% | |
| ICLR |
Icon PLC
Healthcare
|
NEW | 3,659 | $1,035,753 | 6.26% | |
| EHC |
Encompass Health Corp
Healthcare
|
NEW | 12,870 | $858,686 | 5.19% | |
| PODD |
Insulet Corp
Healthcare
|
Reduced | 3,906 | $847,523 | 5.12% | |
|
|
Reduced | 11,631 | $831,035 | 5.02% | ||
| ZBH |
Zimmer Biomet Holdings, Inc.
Healthcare
|
Reduced | 5,646 | $687,118 | 4.15% | |
| AVTR |
Avantor, Inc.
Healthcare
|
Reduced | 24,598 | $561,572 | 3.39% | |
| THC |
Tenet Healthcare Corp
Healthcare
|
Reduced | 7,303 | $551,887 | 3.34% | |
| PFE |
Pfizer Inc
Healthcare
|
NEW | 15,790 | $454,594 | 2.75% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Reduced | 4,650 | $448,353 | 2.71% | |
| KIDS |
Orthopediatrics Corp
Healthcare
|
Reduced | 13,428 | $436,544 | 2.64% | |
| CI |
Cigna Group
Healthcare
|
Reduced | 1,384 | $414,438 | 2.51% | |
| QDEL |
QuidelOrtho Corp
Healthcare
|
Reduced | 5,147 | $379,333 | 2.29% | |
| COO |
Cooper Companies, Inc.
Healthcare
|
Reduced | 988 | $373,898 | 2.26% | |
| SBRA |
Sabra Health Care REIT, Inc.
Real Estate
|
Reduced | 20,017 | $285,642 | 1.73% | |
| A |
Agilent Technologies, Inc.
Healthcare
|
NEW | 1,900 | $264,157 | 1.60% | |
| FTRE |
Fortrea Holdings Inc.
Healthcare
|
NEW | 6,988 | $243,881 | 1.47% | |
| QGEN |
Qiagen N.V.
Healthcare
|
NEW | 5,219 | $233,912 | 1.41% | |
| HUM |
Humana Inc
Healthcare
|
Reduced | 469 | $214,712 | 1.30% | |
| COR |
Cencora, Inc.
Healthcare
|
Reduced | 990 | $203,326 | 1.23% | |
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
NEW | 148,400 | $155,820 | 0.94% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.